Global Esophageal Cancer Drugs Market Growth (Status and Outlook) 2022-2028
- LP 4919367
- 85 Pages
- March 2022
- Pharmaceuticals
The United States Esophageal Cancer Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Esophageal Cancer Drugs market, reaching US$ million by the year 2028. As for the Europe Esophageal Cancer Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Esophageal Cancer Drugs players cover Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, and Merck & Co., Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Esophageal Cancer Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Fluorouracil
Cisplatin
Docetaxel
Carboplatin
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Targeted Therapy
Chemotherapy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Bristol-Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Merck & Co., Inc.
Sanofi
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Esophageal Cancer Drugs Market Size 2017-2028
2.1.2 Esophageal Cancer Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Esophageal Cancer Drugs Segment by Type
2.2.1 Fluorouracil
2.2.2 Cisplatin
2.2.3 Docetaxel
2.2.4 Carboplatin
2.2.5 Others
2.3 Esophageal Cancer Drugs Market Size by Type
2.3.1 Esophageal Cancer Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Esophageal Cancer Drugs Market Size Market Share by Type (2017-2022)
2.4 Esophageal Cancer Drugs Segment by Application
2.4.1 Targeted Therapy
2.4.2 Chemotherapy
2.5 Esophageal Cancer Drugs Market Size by Application
2.5.1 Esophageal Cancer Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Esophageal Cancer Drugs Market Size Market Share by Application (2017-2022)
3 Esophageal Cancer Drugs Market Size by Player
3.1 Esophageal Cancer Drugs Market Size Market Share by Players
3.1.1 Global Esophageal Cancer Drugs Revenue by Players (2020-2022)
3.1.2 Global Esophageal Cancer Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Esophageal Cancer Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Esophageal Cancer Drugs by Regions
4.1 Esophageal Cancer Drugs Market Size by Regions (2017-2022)
4.2 Americas Esophageal Cancer Drugs Market Size Growth (2017-2022)
4.3 APAC Esophageal Cancer Drugs Market Size Growth (2017-2022)
4.4 Europe Esophageal Cancer Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Esophageal Cancer Drugs Market Size Growth (2017-2022)
5 Americas
5.1 Americas Esophageal Cancer Drugs Market Size by Country (2017-2022)
5.2 Americas Esophageal Cancer Drugs Market Size by Type (2017-2022)
5.3 Americas Esophageal Cancer Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Esophageal Cancer Drugs Market Size by Region (2017-2022)
6.2 APAC Esophageal Cancer Drugs Market Size by Type (2017-2022)
6.3 APAC Esophageal Cancer Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Esophageal Cancer Drugs by Country (2017-2022)
7.2 Europe Esophageal Cancer Drugs Market Size by Type (2017-2022)
7.3 Europe Esophageal Cancer Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Esophageal Cancer Drugs by Region (2017-2022)
8.2 Middle East & Africa Esophageal Cancer Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Esophageal Cancer Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Esophageal Cancer Drugs Market Forecast
10.1 Global Esophageal Cancer Drugs Forecast by Regions (2023-2028)
10.1.1 Global Esophageal Cancer Drugs Forecast by Regions (2023-2028)
10.1.2 Americas Esophageal Cancer Drugs Forecast
10.1.3 APAC Esophageal Cancer Drugs Forecast
10.1.4 Europe Esophageal Cancer Drugs Forecast
10.1.5 Middle East & Africa Esophageal Cancer Drugs Forecast
10.2 Americas Esophageal Cancer Drugs Forecast by Country (2023-2028)
10.2.1 United States Esophageal Cancer Drugs Market Forecast
10.2.2 Canada Esophageal Cancer Drugs Market Forecast
10.2.3 Mexico Esophageal Cancer Drugs Market Forecast
10.2.4 Brazil Esophageal Cancer Drugs Market Forecast
10.3 APAC Esophageal Cancer Drugs Forecast by Region (2023-2028)
10.3.1 China Esophageal Cancer Drugs Market Forecast
10.3.2 Japan Esophageal Cancer Drugs Market Forecast
10.3.3 Korea Esophageal Cancer Drugs Market Forecast
10.3.4 Southeast Asia Esophageal Cancer Drugs Market Forecast
10.3.5 India Esophageal Cancer Drugs Market Forecast
10.3.6 Australia Esophageal Cancer Drugs Market Forecast
10.4 Europe Esophageal Cancer Drugs Forecast by Country (2023-2028)
10.4.1 Germany Esophageal Cancer Drugs Market Forecast
10.4.2 France Esophageal Cancer Drugs Market Forecast
10.4.3 UK Esophageal Cancer Drugs Market Forecast
10.4.4 Italy Esophageal Cancer Drugs Market Forecast
10.4.5 Russia Esophageal Cancer Drugs Market Forecast
10.5 Middle East & Africa Esophageal Cancer Drugs Forecast by Region (2023-2028)
10.5.1 Egypt Esophageal Cancer Drugs Market Forecast
10.5.2 South Africa Esophageal Cancer Drugs Market Forecast
10.5.3 Israel Esophageal Cancer Drugs Market Forecast
10.5.4 Turkey Esophageal Cancer Drugs Market Forecast
10.5.5 GCC Countries Esophageal Cancer Drugs Market Forecast
10.6 Global Esophageal Cancer Drugs Forecast by Type (2023-2028)
10.7 Global Esophageal Cancer Drugs Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Bristol-Myers Squibb Company
11.1.1 Bristol-Myers Squibb Company Company Information
11.1.2 Bristol-Myers Squibb Company Esophageal Cancer Drugs Product Offered
11.1.3 Bristol-Myers Squibb Company Esophageal Cancer Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Bristol-Myers Squibb Company Main Business Overview
11.1.5 Bristol-Myers Squibb Company Latest Developments
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Information
11.2.2 Eli Lilly and Company Esophageal Cancer Drugs Product Offered
11.2.3 Eli Lilly and Company Esophageal Cancer Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Eli Lilly and Company Main Business Overview
11.2.5 Eli Lilly and Company Latest Developments
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Information
11.3.2 F. Hoffmann-La Roche Ltd Esophageal Cancer Drugs Product Offered
11.3.3 F. Hoffmann-La Roche Ltd Esophageal Cancer Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 F. Hoffmann-La Roche Ltd Main Business Overview
11.3.5 F. Hoffmann-La Roche Ltd Latest Developments
11.4 Merck & Co., Inc.
11.4.1 Merck & Co., Inc. Company Information
11.4.2 Merck & Co., Inc. Esophageal Cancer Drugs Product Offered
11.4.3 Merck & Co., Inc. Esophageal Cancer Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Merck & Co., Inc. Main Business Overview
11.4.5 Merck & Co., Inc. Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Esophageal Cancer Drugs Product Offered
11.5.3 Sanofi Esophageal Cancer Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
12 Research Findings and Conclusion
Table 1. Esophageal Cancer Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Fluorouracil
Table 3. Major Players of Cisplatin
Table 4. Major Players of Docetaxel
Table 5. Major Players of Carboplatin
Table 6. Major Players of Others
Table 7. Esophageal Cancer Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Esophageal Cancer Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Esophageal Cancer Drugs Market Size Market Share by Type (2017-2022)
Table 10. Esophageal Cancer Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Esophageal Cancer Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Esophageal Cancer Drugs Market Size Market Share by Application (2017-2022)
Table 13. Global Esophageal Cancer Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Esophageal Cancer Drugs Revenue Market Share by Player (2020-2022)
Table 15. Esophageal Cancer Drugs Key Players Head office and Products Offered
Table 16. Esophageal Cancer Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Esophageal Cancer Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Esophageal Cancer Drugs Market Size Market Share by Regions (2017-2022)
Table 21. Americas Esophageal Cancer Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Esophageal Cancer Drugs Market Size Market Share by Country (2017-2022)
Table 23. Americas Esophageal Cancer Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Esophageal Cancer Drugs Market Size Market Share by Type (2017-2022)
Table 25. Americas Esophageal Cancer Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Esophageal Cancer Drugs Market Size Market Share by Application (2017-2022)
Table 27. APAC Esophageal Cancer Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Esophageal Cancer Drugs Market Size Market Share by Region (2017-2022)
Table 29. APAC Esophageal Cancer Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Esophageal Cancer Drugs Market Size Market Share by Type (2017-2022)
Table 31. APAC Esophageal Cancer Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Esophageal Cancer Drugs Market Size Market Share by Application (2017-2022)
Table 33. Europe Esophageal Cancer Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Esophageal Cancer Drugs Market Size Market Share by Country (2017-2022)
Table 35. Europe Esophageal Cancer Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Esophageal Cancer Drugs Market Size Market Share by Type (2017-2022)
Table 37. Europe Esophageal Cancer Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Esophageal Cancer Drugs Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Esophageal Cancer Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Esophageal Cancer Drugs Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Esophageal Cancer Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Esophageal Cancer Drugs Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Esophageal Cancer Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Esophageal Cancer Drugs Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Esophageal Cancer Drugs
Table 46. Key Market Challenges & Risks of Esophageal Cancer Drugs
Table 47. Key Industry Trends of Esophageal Cancer Drugs
Table 48. Global Esophageal Cancer Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Esophageal Cancer Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Esophageal Cancer Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Esophageal Cancer Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Esophageal Cancer Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Esophageal Cancer Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 54. Bristol-Myers Squibb Company Details, Company Type, Esophageal Cancer Drugs Area Served and Its Competitors
Table 55. Bristol-Myers Squibb Company Esophageal Cancer Drugs Product Offered
Table 56. Bristol-Myers Squibb Company Esophageal Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Bristol-Myers Squibb Company Main Business
Table 58. Bristol-Myers Squibb Company Latest Developments
Table 59. Eli Lilly and Company Details, Company Type, Esophageal Cancer Drugs Area Served and Its Competitors
Table 60. Eli Lilly and Company Esophageal Cancer Drugs Product Offered
Table 61. Eli Lilly and Company Main Business
Table 62. Eli Lilly and Company Esophageal Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Eli Lilly and Company Latest Developments
Table 64. F. Hoffmann-La Roche Ltd Details, Company Type, Esophageal Cancer Drugs Area Served and Its Competitors
Table 65. F. Hoffmann-La Roche Ltd Esophageal Cancer Drugs Product Offered
Table 66. F. Hoffmann-La Roche Ltd Main Business
Table 67. F. Hoffmann-La Roche Ltd Esophageal Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. F. Hoffmann-La Roche Ltd Latest Developments
Table 69. Merck & Co., Inc. Details, Company Type, Esophageal Cancer Drugs Area Served and Its Competitors
Table 70. Merck & Co., Inc. Esophageal Cancer Drugs Product Offered
Table 71. Merck & Co., Inc. Main Business
Table 72. Merck & Co., Inc. Esophageal Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Merck & Co., Inc. Latest Developments
Table 74. Sanofi Details, Company Type, Esophageal Cancer Drugs Area Served and Its Competitors
Table 75. Sanofi Esophageal Cancer Drugs Product Offered
Table 76. Sanofi Main Business
Table 77. Sanofi Esophageal Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. Sanofi Latest Developments
List of Figures
Figure 1. Esophageal Cancer Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Esophageal Cancer Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Esophageal Cancer Drugs Market Size Market Share by Type in 2021
Figure 7. Esophageal Cancer Drugs in Targeted Therapy
Figure 8. Global Esophageal Cancer Drugs Market: Targeted Therapy (2017-2022) & ($ Millions)
Figure 9. Esophageal Cancer Drugs in Chemotherapy
Figure 10. Global Esophageal Cancer Drugs Market: Chemotherapy (2017-2022) & ($ Millions)
Figure 11. Global Esophageal Cancer Drugs Market Size Market Share by Application in 2021
Figure 12. Global Esophageal Cancer Drugs Revenue Market Share by Player in 2021
Figure 13. Global Esophageal Cancer Drugs Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Esophageal Cancer Drugs Market Size 2017-2022 ($ Millions)
Figure 15. APAC Esophageal Cancer Drugs Market Size 2017-2022 ($ Millions)
Figure 16. Europe Esophageal Cancer Drugs Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Esophageal Cancer Drugs Market Size 2017-2022 ($ Millions)
Figure 18. Americas Esophageal Cancer Drugs Value Market Share by Country in 2021
Figure 19. Americas Esophageal Cancer Drugs Consumption Market Share by Type in 2021
Figure 20. Americas Esophageal Cancer Drugs Market Size Market Share by Application in 2021
Figure 21. United States Esophageal Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Esophageal Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Esophageal Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Esophageal Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Esophageal Cancer Drugs Market Size Market Share by Region in 2021
Figure 26. APAC Esophageal Cancer Drugs Market Size Market Share by Application in 2021
Figure 27. China Esophageal Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Esophageal Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Esophageal Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Esophageal Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Esophageal Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Esophageal Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Esophageal Cancer Drugs Market Size Market Share by Country in 2021
Figure 34. Europe Esophageal Cancer Drugs Market Size Market Share by Type in 2021
Figure 35. Europe Esophageal Cancer Drugs Market Size Market Share by Application in 2021
Figure 36. Germany Esophageal Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Esophageal Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Esophageal Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Esophageal Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Esophageal Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Esophageal Cancer Drugs Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Esophageal Cancer Drugs Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Esophageal Cancer Drugs Market Size Market Share by Application in 2021
Figure 44. Egypt Esophageal Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Esophageal Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Esophageal Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Esophageal Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Esophageal Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Esophageal Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 50. APAC Esophageal Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 51. Europe Esophageal Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Esophageal Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 53. United States Esophageal Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 54. Canada Esophageal Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Esophageal Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Esophageal Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 57. China Esophageal Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 58. Japan Esophageal Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 59. Korea Esophageal Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Esophageal Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 61. India Esophageal Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Australia Esophageal Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 63. Germany Esophageal Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 64. France Esophageal Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 65. UK Esophageal Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 66. Italy Esophageal Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 67. Russia Esophageal Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 68. Spain Esophageal Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Esophageal Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Esophageal Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Israel Esophageal Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Esophageal Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Esophageal Cancer Drugs Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
